Search

Your search keyword '"Martinucci, I."' showing total 50 results

Search Constraints

Start Over You searched for: Author "Martinucci, I." Remove constraint Author: "Martinucci, I." Database Unpaywall Remove constraint Database: Unpaywall
50 results on '"Martinucci, I."'

Search Results

2. OC.09.6 CLINICAL AND IMPEDANCE-PH FACTORS ASSOCIATED TO PPI RESPONSE IN PATIENTS WITH WITH EXTRAESOPHAGEAL SYMPTOMS SUGGESTIVE OF GERD

4. OC.06.5 LOW-FODMAP DIET RESULTED EFFECTIVE IN REDUCING SYMPTOM PERCEPTION IN PATIENTS WITH FUNCTIONAL HEARTBURN: RANDOMIZED, CROSS-OVER CONTROLLED STUDY

5. P.06.9 MULTIPLE RAPID SWALLOW MIGHT BE HELPFUL TO IMPROVE THE DIAGNOSIS OF INEFFECTIVE ESOPHAGEAL MOTILITY

6. Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time

7. OC.15.2: Low-Volume Multiple Rapid Swallow Better Distinguishes Peristaltic Esophageal Reserve Compared to High-Volume Rapid Drinking Test

8. P.01.6: Vigor of Contraction is Directly Related to Esophageal Chemical Clearance (PSPW Index)

9. OC.15.1: High-Volume Rapid Drinking test Better Distinguishes Esophageal Body Inhibition Compared to Low-Volume Multiple Rapid Swallows

10. OC.15.4: High Resolution Manometry Should be Considered the best Test to Diagnose Sliding Hiatal Hernia

11. OC.15.5: Post-Reflux Swallow-Induced Peristaltic wave Index and Mean Nocturnal Baseline Impedance Predict Heartburn Response to Proton PUMP Inhibitors Better than Acid Exposure Time

13. P.01.12: The Abdominal Length of Lower Esophageal Sphincter is Inversely Correlated with Abnormal Esophageal Acid Exposure

14. The added diagnostic value of postreflux swallow‐induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on‐therapy impedance‐pH monitoring

15. P.08.3 BASELINE IMPEDANCE VALUES CAN REPRESENT A MARKER OF GASTROESOPHAGEAL REFLUX DISEASE AND ARE STRONGLY RELATED WITH THE DURATION OF THE DISEASE

16. P.09.4 THREE-DIMENSIONAL HIGH-RESOLUTION ANORECTAL MANOMETRY AND RECTOANAL DELTA CONTRACTILE INTEGRAL FOR THE ASSESSMENT OF FUNCTIONAL DEFECATORY DISORDERS: TOY OR TOOL?

17. OC.07.2 FUNCTIONAL HEARTBURN OVERLAPS WITH IRRITABLE BOWEL SYNDROME MORE OFTEN THAN GERD. DEVELOPMENT OF PREDICTIVE MODELS WITH NOMOGRAMS

18. PC.01.5 A NEW SUB-CLASSIFICATION OF ESOPHAGO-GASTRIC JUNCTION MORPHOLOGY TYPE I HELPS TO BETTER RECOGNIZE PATIENTS WITH A POSITIVE IMPEDANCE-PH MONITORING

19. OC.05.2 HIGH RESOLUTION MANOMETRY AND CLINICAL CHARACTERISTICS OF PATIENTS WITH OUTFLOW OBSTRUCTION: IS THIS A TRULY RELEVANT NOVEL MANOMETRIC DIAGNOSIS?

22. P.10.5 BERBERINE, TOCOTRIENOLS AND GREEN DECAFFEINATED COFFEE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE: EFFECT OF FULL AND HALF DOSE TREATMENT. SINGLE-CENTRE OBSERVATIONAL STUDY

23. Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD

24. Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: a comparative study

25. Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure

27. P.10.21 PATIENTS WITH NEGATIVE IMPEDANCE AND PH WHO RESPOND TO ACID SUPPRESSION: ARE THEY HYPERSENSITIVE PATIENTS? A STUDY WITH BASELINE IMPEDANCE VALUES AND PSPW INDEX

28. OC.02.2 REFLUX PATTERN AND ROLE OF IMPEDANCE-PH VARIABLES IN PREDICTING PPI RESPONSE IN PATIENTS WITH SUSPECTED GERD-RELATED CHRONIC COUGH

35. OC.06.1 USE OF A NON-INVASIVE PEPSIN DIAGNOSTIC TEST TO DETECT GERD: CORRELATION WITH MII-pH EVALUATION IN A SERIES OF SUSPECTED NERD PATIENTS. A PILOT STUDY

41. P.20.7 IMPEDANCE-PH MONITORING AND SYMPTOM ANALYSIS IN NON-CARDIAC CHEST PAIN PATIENTS ON AND OFF THERAPY

43. P.10.11 SYMPTOMS ASSOCIATED TO WEAKLY ACIDIC REFLUX AND ESOPHAGEAL MOTILITY ABNORMALITIES ARE COMMON FINDINGS IN PATIENTS WITH NCCP NON-RESPONDING TO PPI THERAPY

44. P.19.6 SERUM PEPSINOGEN I AND GASTRIN-17 LEVELS ARE PREDICTABLE OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROIDITIS AND ANTI-GASTRIC PARIETAL CELL AUTOANTIBODIES

45. Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year

50. P.209 HIGH PREVALENCE OF EROSIVE ESOPHAGITIS AND LOW PREVALENCE OF GERD SYMPTOMS IN A GROUP OF OBESE PATIENTS

Catalog

Books, media, physical & digital resources